- Home
- FND vs ARWR Comparison
FND vs ARWR Comparison
Compare FND & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FND
- ARWR
- Stock Information
- Founded
- FND 2000
- ARWR 2003
- Country
- FND United States
- ARWR United States
- Employees
- FND N/A
- ARWR N/A
- Industry
- FND RETAIL: Building Materials
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- FND Consumer Discretionary
- ARWR Health Care
- Exchange
- FND Nasdaq
- ARWR Nasdaq
- Market Cap
- FND 6.7B
- ARWR 5.9B
- IPO Year
- FND 2017
- ARWR 1993
- Fundamental
- Price
- FND $63.60
- ARWR $41.78
- Analyst Decision
- FND Hold
- ARWR Buy
- Analyst Count
- FND 17
- ARWR 9
- Target Price
- FND $83.24
- ARWR $47.44
- AVG Volume (30 Days)
- FND 2.7M
- ARWR 1.7M
- Earning Date
- FND 10-30-2025
- ARWR 11-25-2025
- Dividend Yield
- FND N/A
- ARWR N/A
- EPS Growth
- FND 11.08
- ARWR N/A
- EPS
- FND 2.00
- ARWR N/A
- Revenue
- FND $4,661,833,000.00
- ARWR $572,976,000.00
- Revenue This Year
- FND $6.27
- ARWR $21,287.22
- Revenue Next Year
- FND $8.05
- ARWR N/A
- P/E Ratio
- FND $31.57
- ARWR N/A
- Revenue Growth
- FND 6.04
- ARWR 2816.20
- 52 Week Low
- FND $58.01
- ARWR $9.57
- 52 Week High
- FND $122.90
- ARWR $43.69
- Technical
- Relative Strength Index (RSI)
- FND 40.67
- ARWR 63.13
- Support Level
- FND $58.01
- ARWR $38.93
- Resistance Level
- FND $62.60
- ARWR $42.00
- Average True Range (ATR)
- FND 2.95
- ARWR 2.24
- MACD
- FND -0.11
- ARWR -0.16
- Stochastic Oscillator
- FND 33.42
- ARWR 73.42
About FND Floor & Decor Holdings Inc.
Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.